The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication

by Accolla Roberto S, Mortara Lorenzo, Barbaro Andrea, Tosi Giovanna
Published 2005-12-01

7he MHC Class II Transactivator (CIITA): A Physiologic Inhibitor of HTLV-2 Retroviral Infection

by Casoli Claudio, Mortara Lorenzo, Barbaro Andrea, Pilotti Elisabetta, Tosi Giovanna, Accolla Roberto S
Published 2005-12-01

Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study

by Giusti Massimo, Mortara Lorenzo, Degrandi Roberta, Cecoli Francesca, Mussap Michele, Rodriguez Guido, Ferone Diego, Minuto Francesco
Published 2008-09-01

SIV escape mutants in rhesus macaques vaccinated with NEF-derived lipopeptides and challenged with pathogenic SIVmac251

by Mortara Lorenzo, Coutsinos Zoe, Letourneur Franck, Villefroy Pascale, Beyer Christian, Gras-Masse Helene, Guillet Jean-Gerard, Bourgault-Villada Isabelle
Published 2006-08-01

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels

by Zardi Luciano, Accollo Roberto, Castellani Patrizia, Neri Dario, Carnemolla Barbara, Monteghirfo Stefano, Sassi Francesca, Mortara Lorenzo, Balza Enrica, Borsi Laura
Published 2006-12-01